Monitoring Dialysis Patients On Erythropoietin Therapy

At the start of treatment, patients receiving erythropoietin require fairly close monitoring every 2–4 weeks. As a minimum, the hemoglobin should be measured, there should be an assessment of iron status, and blood pressure should be checked.

How To Treat Anemia By Erythropoietin Therapy?

There are two important reasons to correct anemia in renal failure patients. One is to improve or reverse the symptoms associated with renal anemia, and the second is to seize or reverse the deleterious effect of long-standing anemia on the heart and other organs which lead to improved cardiovascular morbidity and mortality in dialysis patients.

Action Of Erythropoietin In Dialysis Patients

Erythropoietin therapy is one of the greatest inventions in Nephrology and it changed the way we treat anemic patients, which we were only dependent on blood transfusions in the past. Erythropoietin therapy is the easiest way to treat anemia in CKD

Management of Anemia in Chronic Kidney Disease (CKD)

There are two important reasons to correct anemia in renal failure patients. One is to improve or reverse the symptoms associated with renal anemia, and the second is to seize or reverse the deleterious effect of long-standing anemia on the heart and other organs which lead to improved cardiovascular morbidity and mortality in dialysis patients.

Development Of Anemia In Dialysis Patients

Anemia is one of the major Hematological complications in Chronic Kidney Disease (CKD). As renal function declines, there is a progressive worsening of anemia, which becomes clear once serum creatinine rises above 300 µmol/L or GFR falls below 30 ml/min/1.73m² and its major cause is the loss of cells in the kidney responsible for the synthesis and secretion of erythropoietin.

Anemia In Dialysis Patients

Anemia is one of the major Hematological complications in Chronic Kidney Disease (CKD). Although anemia in CKD is multifactorial by far the main cause of anemia is due to inadequate production of hormone Erythropoietin by the diseased kidneys.